Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1186 AL 1200

Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study

Schapira AH, Albrecht S, Barone P, Comella CL, McDermott MP, Mizuno Y, Poewe W, Rascol O, Marek K.

Mov Disord. 2010 Aug 15;25(11):1627-32. doi: 10.1002/mds.23143.

Congenital mirror movements in Parkinson's disease: clinical and neurophysiological observations

Borgheresi A, Espay AJ, Giovannelli F, Vanni P, Zaccara G, Cincotta M.

Mov Disord. 2010 Jul 30;25(10):1520-3. doi: 10.1002/mds.23142.

Genetic animal models of Parkinson's disease

Dawson TM, Ko HS, Dawson VL.

Neuron. 2010 Jun 10;66(5):646-61. doi: 10.1016/j.neuron.2010.04.034.

R492X mutation in PTEN-induced putative kinase 1 induced cellular mitochondrial dysfunction and oxidative stress

Yuan XL, Guo JF, Shi ZH, Xiao ZQ, Yan XX, Zhao BL, Tang BS.

Brain Res. 2010 Sep 10;1351:229-237. doi: 10.1016/j.brainres.2010.06.005. Epub 2010 Jun 12.

Can we improve the inpatient care of those with Parkinson's disease?

Donaldson S.

Postgrad Med J. 2010 Jun;86(1016):321-2. doi: 10.1136/pgmj.2009.095083.

Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study

Bajaj NP, Gontu V, Birchall J, Patterson J, Grosset DG, Lees AJ.

J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1223-8. doi: 10.1136/jnnp.2009.193391. Epub 2010 Jun 14.

Hypermetabolism in patients with dementia with Lewy bodies

Miyazawa N, Shinohara T, Nagasaka T, Hayashi M.

Clin Nucl Med. 2010 Jul;35(7):490-3. doi: 10.1097/RLU.0b013e3181e05dbc.

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease

Maguire-Zeiss KA, Federoff HJ.

J Neural Transm (Vienna). 2010 Aug;117(8):1019-25. doi: 10.1007/s00702-010-0431-6. Epub 2010 Jun 12.

A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia

Nasrallah HA, Gopal S, Gassmann-Mayer C, Quiroz JA, Lim P, Eerdekens M, Yuen E, Hough D.

Neuropsychopharmacology. 2010 Sep;35(10):2072-82. doi: 10.1038/npp.2010.79. Epub 2010 Jun 16.

Improving gait and promoting retention in individuals with Parkinson's disease: a pilot study

Werner WG, Gentile AM.

J Neurol. 2010 Nov;257(11):1841-7. doi: 10.1007/s00415-010-5619-z. Epub 2010 Jun 17.

Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders

Sánchez MG, Bourque M, Morissette M, Di Paolo T.

CNS Neurosci Ther. 2010 Jun;16(3):e43-71. doi: 10.1111/j.1755-5949.2010.00163.x.

Paeoniflorin, a potent natural compound, protects PC12 cells from MPP+ and acidic damage via autophagic pathway

Cao BY, Yang YP, Luo WF, Mao CJ, Han R, Sun X, Cheng J, Liu CF.

J Ethnopharmacol. 2010 Aug 19;131(1):122-9. doi: 10.1016/j.jep.2010.06.009. Epub 2010 Jun 15.

Nonmotor symptoms in genetic Parkinson disease

Kasten M, Kertelge L, Brüggemann N, van der Vegt J, Schmidt A, Tadic V, Buhmann C, Steinlechner S, Behrens MI, Ramirez A, Binkofski F, Siebner H, Raspe H, Hagenah J, Lencer R, Klein C.

Arch Neurol. 2010 Jun;67(6):670-6. doi: 10.1001/archneurol.67.6.670.

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study

Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Ross BM, Cote LJ, Frucht S, Ford B, Alcalay RN, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Neils GD, Verbitsky M, Kisselev S, Caccappolo E, Ottman R, Clark LN.

Arch Neurol. 2010 Jun;67(6):731-8. doi: 10.1001/archneurol.2010.95.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias